Europe Oncology Drugs Industry Market Analysis & Forecast 2018-2023

June 2018 | 137 pages | ID: EB9C26C2272EN
S&P Consulting

Abstracts

In the Europe Oncology Drugs Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is forecasted to reach XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023.

It covers Regional Segment Analysis, Type, Appliction, Major Manufactures, Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.

Europe Oncology Drugs Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Roche
Novartis
Celgene
Amgen
Johnson & Johnson
GlaxoSmithKline
Eli lilly & Co
Pfizer
Merck & Co.

Europe Oncology Drugs Market Analysis by Product:
Blood Cancer
Breast Cancer
Others

Europe Oncology Drugs Market Analysis by Application:
Chemotherapy
Targeted Therapy
Others

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 ONCOLOGY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Oncology Drugs
1.2 Classification of Oncology Drugs
  1.2.1 Blood Cancer
  1.2.2 Breast Cancer
  1.2.3 Others
1.3 Application of Oncology Drugs
  1.3.2 Chemotherapy
  1.3.3 Targeted Therapy
  1.3.4 Others
1.4 Oncology Drugs Market States Status and Prospect (2013-2023) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Oncology Drugs (2013-2023)
  1.5.1 Europe Oncology Drugs Sales and Growth Rate (2013-2023)
  1.5.2 Europe Oncology Drugs Revenue and Growth Rate (2013-2023)

2 EUROPE ECONOMIC IMPACT ON ONCOLOGY DRUGS INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 ONCOLOGY DRUGS MANUFACTURING COST ANALYSIS

3.1 Oncology Drugs Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Oncology Drugs

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Oncology Drugs Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Oncology Drugs Major Manufacturers in 2016
4.4 Downstream Buyers

5 EUROPE ONCOLOGY DRUGS MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Oncology Drugs Market Competition by Manufacturers
  5.1.1 Europe Oncology Drugs Sales and Market Share of Key Manufacturers (2016 and 2017)
  5.1.2 Europe Oncology Drugs Revenue and Share by Manufacturers (2016 and 2017)
5.2 Europe Oncology Drugs (Volume and Value) by Type
  5.2.1 Europe Oncology Drugs Sales and Market Share by Type (2013-2018)
  5.2.2 Europe Oncology Drugs Revenue and Market Share by Type (2013-2018)
5.3 Europe Oncology Drugs (Volume and Value) by Countries
  5.3.1 Europe Oncology Drugs Sales and Market Share by Countries (2013-2018)
  5.3.2 Europe Oncology Drugs Revenue and Market Share by Countries (2013-2018)
5.4 Europe Oncology Drugs (Volume) by Application

6 GERMANY ONCOLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Oncology Drugs Sales and Value (2013-2018)
  6.1.1 Germany Oncology Drugs Sales and Growth Rate (2013-2018)
  6.1.2 Germany Oncology Drugs Revenue and Growth Rate (2013-2018)
  6.1.3 Germany Oncology Drugs Sales Price Trend (2013-2018)
6.2 Germany Oncology Drugs Sales and Market Share by Manufacturers
6.3 Germany Oncology Drugs Sales and Market Share by Type
6.4 Germany Oncology Drugs Sales and Market Share by Application

7 FRANCE ONCOLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 France Oncology Drugs Sales and Value (2013-2018)
  7.1.1 France Oncology Drugs Sales and Growth Rate (2013-2018)
  7.1.2 France Oncology Drugs Revenue and Growth Rate (2013-2018)
  7.1.3 France Oncology Drugs Sales Price Trend (2013-2018)
7.2 France Oncology Drugs Sales and Market Share by Manufacturers
7.3 France Oncology Drugs Sales and Market Share by Type
7.4 France Oncology Drugs Sales and Market Share by Application

8 UK ONCOLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 UK Oncology Drugs Sales and Value (2013-2018)
  8.1.1 UK Oncology Drugs Sales and Growth Rate (2013-2018)
  8.1.2 UK Oncology Drugs Revenue and Growth Rate (2013-2018)
  8.1.3 UK Oncology Drugs Sales Price Trend (2013-2018)
8.2 UK Oncology Drugs Sales and Market Share by Manufacturers
8.3 UK Oncology Drugs Sales and Market Share by Type
8.4 UK Oncology Drugs Sales and Market Share by Application

9 RUSSIA ONCOLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Oncology Drugs Sales and Value (2013-2018)
  9.1.1 Russia Oncology Drugs Sales and Growth Rate (2013-2018)
  9.1.2 Russia Oncology Drugs Revenue and Growth Rate (2013-2018)
  9.1.3 Russia Oncology Drugs Sales Price Trend (2013-2018)
9.2 Russia Oncology Drugs Sales and Market Share by Manufacturers
9.3 Russia Oncology Drugs Sales and Market Share by Type
9.4 Russia Oncology Drugs Sales and Market Share by Application

10 ITALY ONCOLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Oncology Drugs Sales and Value (2013-2018)
  10.1.1 Italy Oncology Drugs Sales and Growth Rate (2013-2018)
  10.1.2 Italy Oncology Drugs Revenue and Growth Rate (2013-2018)
  10.1.3 Italy Oncology Drugs Sales Price Trend (2013-2018)
10.2 Italy Oncology Drugs Sales and Market Share by Manufacturers
10.3 Italy Oncology Drugs Sales and Market Share by Type
10.4 Italy Oncology Drugs Sales and Market Share by Application

11 SPAIN ONCOLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Oncology Drugs Sales and Value (2013-2018)
  11.1.1 Spain Oncology Drugs Sales and Growth Rate (2013-2018)
  11.1.2 Spain Oncology Drugs Revenue and Growth Rate (2013-2018)
  11.1.3 Spain Oncology Drugs Sales Price Trend (2013-2018)
11.2 Spain Oncology Drugs Sales and Market Share by Manufacturers
11.3 Spain Oncology Drugs Sales and Market Share by Type
11.4 Spain Oncology Drugs Sales and Market Share by Application

12 BENELUX ONCOLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Oncology Drugs Sales and Value (2013-2018)
  12.1.1 Benelux Oncology Drugs Sales and Growth Rate (2013-2018)
  12.1.2 Benelux Oncology Drugs Revenue and Growth Rate (2013-2018)
  12.1.3 Benelux Oncology Drugs Sales Price Trend (2013-2018)
12.2 Benelux Oncology Drugs Sales and Market Share by Manufacturers
12.3 Benelux Oncology Drugs Sales and Market Share by Type
12.4 Benelux Oncology Drugs Sales and Market Share by Application

13 EUROPE ONCOLOGY DRUGS MANUFACTURERS ANALYSIS

13.1 Roche
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2013-2018)
  13.1.4 Business Overview
13.2 Novartis
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2013-2018)
  13.2.4 Business Overview
13.3 Celgene
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2013-2018)
  13.3.4 Business Overview
13.4 Amgen
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2013-2018)
  13.4.4 Business Overview
13.5 Johnson & Johnson
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2013-2018)
  13.5.4 Business Overview
13.6 GlaxoSmithKline
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
  13.6.4 Business Overview
13.7 Eli lilly & Co
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2013-2018)
  13.7.4 Business Overview
13.8 Pfizer
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2013-2018)
  13.8.4 Business Overview
13.9 Merck & Co.
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2013-2018)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE ONCOLOGY DRUGS MARKET FORECAST (2018-2023)

15.1 Germany Market Forecast (2018-2023)
15.2 France Market Forecast (2018-2023)
15.3 UK Market Forecast (2018-2023)
15.4 Russia Market Forecast (2018-2023)
15.5 Italy Market Forecast (2018-2023)
15.6 Spain Market Forecast (2018-2023)
15.7 Benelux Market Forecast (2018-2023)
15.8 Europe Oncology Drugs Market Forecast by Type (2018-2023)
15.9 Europe Oncology Drugs Market Forecast by Application (2018-2023)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Oncology Drugs
Table Classification of Oncology Drugs
Figure Europe Sales Market Share of Oncology Drugs by Type in 2016
Table Application of Oncology Drugs
Figure Europe Sales Market Share of Oncology Drugs by Application in 2016
Figure Germany Oncology Drugs Revenue and Growth Rate (2013-2023)
Figure France Oncology Drugs Revenue and Growth Rate (2013-2023)
Figure UK Oncology Drugs Revenue and Growth Rate (2013-2023)
Figure Russia Oncology Drugs Revenue and Growth Rate (2013-2023)
Figure Italy Oncology Drugs Revenue and Growth Rate (2013-2023)
Figure Spain Oncology Drugs Revenue and Growth Rate (2013-2023)
Figure Benelux Oncology Drugs Revenue and Growth Rate (2013-2023)
Figure Europe Oncology Drugs Sales and Growth Rate (2013-2023)
Figure Europe Oncology Drugs Revenue and Growth Rate (2013-2023)
Table Europe Oncology Drugs Sales of Key Manufacturers (2016 and 2017)
Table Europe Oncology Drugs Sales Share by Manufacturers (2016 and 2017)
Figure 2015 Oncology Drugs Sales Share by Manufacturers
Figure 2016 Oncology Drugs Sales Share by Manufacturers
Table Europe Oncology Drugs Revenue by Manufacturers (2016 and 2017)
Table Europe Oncology Drugs Revenue Share by Manufacturers (2016 and 2017)
Table 2015 Europe Oncology Drugs Revenue Share by Manufacturers
Table 2016 Europe Oncology Drugs Revenue Share by Manufacturers
Table Europe Oncology Drugs Sales and Market Share by Type (2013-2018)
Table Europe Oncology Drugs Sales Share by Type (2013-2018)
Figure Sales Market Share of Oncology Drugs by Type (2013-2018)
Figure Europe Oncology Drugs Sales Growth Rate by Type (2013-2018)
Table Europe Oncology Drugs Revenue and Market Share by Type (2013-2018)
Table Europe Oncology Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Oncology Drugs by Type (2013-2018)
Figure Europe Oncology Drugs Revenue Growth Rate by Type (2013-2018)
Table Europe Oncology Drugs Sales and Market Share by Countries (2013-2018)
Table Europe Oncology Drugs Sales Share by Countries (2013-2018)
Figure Sales Market Share of Oncology Drugs by Countries (2013-2018)
Table Europe Oncology Drugs Revenue and Market Share by Countries (2013-2018)
Table Europe Oncology Drugs Revenue Share by Countries (2013-2018)
Figure Revenue Market Share of Oncology Drugs by Countries (2013-2018)
Table Europe Oncology Drugs Sales and Market Share by Application (2013-2018)
Table Europe Oncology Drugs Sales Share by Application (2013-2018)
Figure Sales Market Share of Oncology Drugs by Application (2013-2018)
Figure Germany Oncology Drugs Sales and Growth Rate (2013-2018)
Figure Germany Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Germany Oncology Drugs Sales Price Trend (2013-2018)
Table Germany Oncology Drugs Sales by Manufacturers (2016 and 2017)
Table Germany Oncology Drugs Market Share by Manufacturers (2016 and 2017)
Table Germany Oncology Drugs Sales by Type (2016 and 2017)
Table Germany Oncology Drugs Market Share by Type (2016 and 2017)
Table Germany Oncology Drugs Sales by Application (2016 and 2017)
Table Germany Oncology Drugs Market Share by Application (2016 and 2017)
Figure France Oncology Drugs Sales and Growth Rate (2013-2018)
Figure France Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure France Oncology Drugs Sales Price Trend (2013-2018)
Table France Oncology Drugs Sales by Manufacturers (2016 and 2017)
Table France Oncology Drugs Market Share by Manufacturers (2016 and 2017)
Table France Oncology Drugs Sales by Type (2016 and 2017)
Table France Oncology Drugs Market Share by Type (2016 and 2017)
Table France Oncology Drugs Sales by Application (2016 and 2017)
Table France Oncology Drugs Market Share by Application (2016 and 2017)
Figure UK Oncology Drugs Sales and Growth Rate (2013-2018)
Figure UK Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure UK Oncology Drugs Sales Price Trend (2013-2018)
Table UK Oncology Drugs Sales by Manufacturers (2016 and 2017)
Table UK Oncology Drugs Market Share by Manufacturers (2016 and 2017)
Table UK Oncology Drugs Sales by Type (2016 and 2017)
Table UK Oncology Drugs Market Share by Type (2016 and 2017)
Table UK Oncology Drugs Sales by Application (2016 and 2017)
Table UK Oncology Drugs Market Share by Application (2016 and 2017)
Figure Russia Oncology Drugs Sales and Growth Rate (2013-2018)
Figure Russia Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Russia Oncology Drugs Sales Price Trend (2013-2018)
Table Russia Oncology Drugs Sales by Manufacturers (2016 and 2017)
Table Russia Oncology Drugs Market Share by Manufacturers (2016 and 2017)
Table Russia Oncology Drugs Sales by Type (2016 and 2017)
Table Russia Oncology Drugs Market Share by Type (2016 and 2017)
Table Russia Oncology Drugs Sales by Application (2016 and 2017)
Table Russia Oncology Drugs Market Share by Application (2016 and 2017)
Figure Italy Oncology Drugs Sales and Growth Rate (2013-2018)
Figure Italy Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Italy Oncology Drugs Sales Price Trend (2013-2018)
Table Italy Oncology Drugs Sales by Manufacturers (2016 and 2017)
Table Italy Oncology Drugs Market Share by Manufacturers (2016 and 2017)
Table Italy Oncology Drugs Sales by Type (2016 and 2017)
Table Italy Oncology Drugs Market Share by Type (2016 and 2017)
Table Italy Oncology Drugs Sales by Application (2016 and 2017)
Table Italy Oncology Drugs Market Share by Application (2016 and 2017)
Figure Spain Oncology Drugs Sales and Growth Rate (2013-2018)
Figure Spain Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Spain Oncology Drugs Sales Price Trend (2013-2018)
Table Spain Oncology Drugs Sales by Manufacturers (2016 and 2017)
Table Spain Oncology Drugs Market Share by Manufacturers (2016 and 2017)
Table Spain Oncology Drugs Sales by Type (2016 and 2017)
Table Spain Oncology Drugs Market Share by Type (2016 and 2017)
Table Spain Oncology Drugs Sales by Application (2016 and 2017)
Table Spain Oncology Drugs Market Share by Application (2016 and 2017)
Figure Benelux Oncology Drugs Sales and Growth Rate (2013-2018)
Figure Benelux Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Benelux Oncology Drugs Sales Price Trend (2013-2018)
Table Benelux Oncology Drugs Sales by Manufacturers (2016 and 2017)
Table Benelux Oncology Drugs Market Share by Manufacturers (2016 and 2017)
Table Benelux Oncology Drugs Sales by Type (2016 and 2017)
Table Benelux Oncology Drugs Market Share by Type (2016 and 2017)
Table Benelux Oncology Drugs Sales by Application (2016 and 2017)
Table Benelux Oncology Drugs Market Share by Application (2016 and 2017)
Table Roche Basic Information List
Table Roche Oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
Figure Roche Oncology Drugs Sales Market Share (2013-2018)
Table Novartis Basic Information List
Table Novartis Oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
Table Novartis Oncology Drugs Sales Market Share (2013-2018)
Table Celgene Basic Information List
Table Celgene Oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
Figure Celgene Oncology Drugs Sales Market Share (2013-2018)
Table Amgen Basic Information List
Table Amgen Oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
Table Amgen Oncology Drugs Sales Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
Figure Johnson & Johnson Oncology Drugs Sales Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
Table GlaxoSmithKline Oncology Drugs Sales Market Share (2013-2018)
Table Eli lilly & Co Basic Information List
Table Eli lilly & Co Oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
Figure Eli lilly & Co Oncology Drugs Sales Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
Table Pfizer Oncology Drugs Sales Market Share (2013-2018)
Table Merck & Co. Basic Information List
Table Merck & Co. Oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
Figure Merck & Co. Oncology Drugs Sales Market Share (2013-2018).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Drugs
Figure Manufacturing Process Analysis of Oncology Drugs
Figure Oncology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Oncology Drugs Major Manufacturers in 2016
Table Major Buyers of Oncology Drugs
Table Distributors/Traders List
Figure Germany Oncology Drugs Sales and Growth Rate Forecast (2018-2023)
Figure Germany Oncology Drugs Revenue and Growth Rate Forecast (2018-2023)
Figure France Oncology Drugs Sales and Growth Rate Forecast (2018-2023)
Figure France Oncology Drugs Revenue and Growth Rate Forecast (2018-2023)
Figure UK Oncology Drugs Sales and Growth Rate Forecast (2018-2023)
Figure UK Oncology Drugs Revenue and Growth Rate Forecast (2018-2023)
Figure Russia Oncology Drugs Sales and Growth Rate Forecast (2018-2023)
Figure Russia Oncology Drugs Revenue and Growth Rate Forecast (2018-2023)
Figure Italy Oncology Drugs Sales and Growth Rate Forecast (2018-2023)
Figure Italy Oncology Drugs Revenue and Growth Rate Forecast (2018-2023)
Figure Spain Oncology Drugs Sales and Growth Rate Forecast (2018-2023)
Figure Spain Oncology Drugs Revenue and Growth Rate Forecast (2018-2023)
Figure Benelux Oncology Drugs Sales and Growth Rate Forecast (2018-2023)
Figure Benelux Oncology Drugs Revenue and Growth Rate Forecast (2018-2023)
Table Europe Oncology Drugs Sales Forecast by Type (2018-2023)
Table Europe Oncology Drugs Sales Forecast by Application (2018-2023)

COMPANIES MENTIONED

Roche Novartis Celgene Amgen Johnson & Johnson GlaxoSmithKline Eli lilly & Co Pfizer Merck & Co.